Molbio developing more tests for Truenat platform

Molbio Diagnostics that invented ‘Truenat Real-time PCR’, the world’s only pointof-care (POC) platform used by the WHO to detect tuberculosis, is now prepping up to come up with more tests on the same platform.

Apart from Covid-19 and tuberculosis, Molbio is preparing test kits for zika, cholera, nipah, sickle cell anaemia, cholera, influenza, mumps, syphillis, yellow fever, HIV2 etc.

Around 30 new tests are on the cards.

The Truenat platform gained traction during the pandemic and in the last one year the firm sold close to 3,000 machines. This is 3X what it had sold in the previous year. Truenat was used as POC detection for Covid in the hinterland where laboratory facilities are rare.

The firm has over 4,000 installations in India, and aims to be a large global player in the molecular diagnostic segment in the coming years.